Key result
The SYNTAX score II (SSII) demonstrated the best predictive capability for all-cause mortality (AUC 0.79, p<0.01) compared to other risk scores in UA/NSTEMI patients undergoing PCI.
Why the study?
Post-revascularization mortality in MVCAD has been explored via several risk scores, but their performance in UA/NSTEMI patients undergoing PCI needed assessment and comparison.
Which risk score best predicts medium to long-term mortality and MACE in UA/NSTEMI patients with multivessel coronary artery disease undergoing PCI?
Observational (n=200)
No
Which risk score best predicts medium to long-term mortality and MACE in UA/NSTEMI patients with multivessel coronary artery disease undergoing PCI?
Effect estimate: AUC 0.79
p-value: p=< 0.01
The SYNTAX score II (SSII) is superior to purely angiographic scores in predicting medium to long-term mortality and MACE in UA/NSTEMI patients with multivessel disease undergoing PCI.
SSII may aid mortality prediction in UA/NSTEMI multivessel PCI; hypothesis-generating and requires prospective validation before practice change.
OBJECTIVE: Post-revascularization mortality in multivessel coronary artery disease (MVCAD) has been explored via several risk scores. Here, we assessed and compared various risk scores in predicting medium to long-term clinical outcomes in unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) patients with MVCAD undergoing percutaneous coronary intervention (PCI). METHODS: We analyzed a cohort of a tertiary care center registry enrolling patients in South India, Kerala, with MVCAD (N = 200) who had undergone PCI between 2010 and 2018. The outcomes evaluated were all-cause mortality and major adverse cardiac events (MACE). The risk scores assessed included SYNTAX score (SS), residual SYNTAX score (rSS), SYNTAX revascularization index (SRI), age, creatinine, and ejection fraction (ACEF) score, clinical SYNTAX score (cSS), and SYNTAX score II (SSII). RESULTS: Of the analyzed risk scores, SSII had the best predictive capability with the area under the curve (AUC) of 0.79 in c-statistics, followed by ACEF score and cSS with AUCs of 0.74 and 0.65, respectively for all-cause mortality (p < 0.01). Kaplan-Meier survival curves and multivariate analysis by Cox regression showed SSII with cut-offs of >35.15 and > 29.55 to be the only score associated with higher mortality and MACE, respectively. CONCLUSIONS: In UA/NSTEMI patients with relatively less complex MVCAD treated by PCI, the SSII, ACEF and cSS risk scores could predict the outcomes better. The SSII showed the best predictive performance for all-cause mortality and MACE. Scores based on baseline and residual atherosclerotic burden (SS, rSS, and SRI) performed poorly in predicting the mortality and MACE.
No takes yet. Share an insight, caveat, or question.
Sebastian et al. (2021) conducted an observational in Unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) with multivessel coronary artery disease (MVCAD) (n=200). SYNTAX score II (SSII) vs. Other risk scores (ACEF, cSS, SS, rSS, SRI) was evaluated on All-cause mortality (AUC 0.79, p=< 0.01). The SYNTAX score II (SSII) demonstrated the best predictive capability for all-cause mortality (AUC 0.79, p<0.01) compared to other risk scores in UA/NSTEMI patients undergoing PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: